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Abstract
Molecular chaperones protect cells from the deleterious effects of protein misfolding and aggregation. Neurotoxicity of
amyloid-beta (Ab) aggregates and their deposition in senile plaques are hallmarks of Alzheimer’s disease (AD). We observed
that the overall content of aB-crystallin, a small heat shock protein molecular chaperone, decreased in AD model mice in an
age-dependent manner. We hypothesized that aB-crystallin protects cells against Ab toxicity. To test this, we crossed aB-
crystallin/HspB2 deficient (CRYAB
-/-HSPB2
-/-) mice with AD model transgenic mice expressing mutant human amyloid
precursor protein. Transgenic and non-transgenic mice in chaperone-sufficient or deficient backgrounds were examined for
representative behavioral paradigms for locomotion and memory network functions: (i) spatial orientation and locomotion
was monitored by open field test; (ii) sequential organization and associative learning was monitored by fear conditioning;
and (iii) evoked behavioral response was tested by hot plate method. Interestingly, aB-crystallin/HspB2 deficient transgenic
mice were severely impaired in locomotion compared to each genetic model separately. Our results highlight a synergistic
effect of combining chaperone deficiency in a transgenic mouse model for AD underscoring an important role for
chaperones in protein misfolding diseases.
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Introduction
Accumulation of misfolded and aggregated proteins is a
pathological hallmark of several neurodegenerative diseases. In
Alzheimer’s disease (AD), aggregated amyloid-beta peptide (Ab)i s
a primary component of the senile plaques and is thought to be
central to the associated neurotoxicity. Because molecular
chaperones have evolved to protect cells against protein misfolding
and aggregation, their importance in protein aggregation diseases
must be understood. Members of the small heat shock proteins
(sHsps) family, whose expression is regulated by the heat shock
transcription factor 1 (HSF1), protect cells from a variety of
environmental conditions such as heat and oxidative stress by
antagonizing protein aggregation. In vivo, sHsps play an important
role in enhancing stress resistance, regulating actin and interme-
diate filament dynamics, and inhibiting apoptosis [1,2]. sHsps
share a conserved a-crystallin domain of 80–100 amino acids at
their C-terminus whereas their N-terminal regions are highly
variable in sequence and length [3,4]. The sHsps form dynamic
oligomeric structures ranging from 9–50 subunits associating as
either homo- or hetero-multimeric complexes [5,6]. It has been
proposed that the ATP-independent sHsps aid in refolding of
denatured proteins by holding them in a reactivation-competent
state and target them to subsequent refolding or degradation with
the help of ATP-dependent chaperones like Hsp70 [2,7].
The human and mouse genomes code for 10 genes for sHsps
differing between 45 and 85% in sequence [8,9]. Of these Hsp27
(Hsp25 in mouse), aB-crystallin, HspB6 and HspB8 are ubiqui-
touslyexpressed[8].PointmutationsinhumansHspslead toseveral
aggregation diseases [10] – for example, mutations in aA-crystallin
leads to cataract [11], mutations in aB-crystallin leads to desmin-
related myopathy [12,13,14], missense mutations in HSP27 is
associated with Charcot-Marie-Tooth disease [15]. Over-expres-
sion of Hsp27 is highly protective against toxicity induced by aSyn
[16] or polyglutamine [17] in cell culture models. Hsp27 and aB-
crystallin have been found in proteinaceous inclusions of Alzhei-
mer’s and Parkinson’s disease [18,19,20,21,22,23,24]. The sHsps
are associated with senescence and longevity in worms [25,26] and
flies [27] suggesting their importance in aging-related diseases.
Induction of aB-crystallin has been noted in Alexander’s disease
[28], Creutzfeldt-Jacob disease [22] and Alzheimer’s disease [29].
Interestingly, the amyloid precursor protein (APP) central to AD
was found to interact with aB-crystallin in worm [30] and
mammalian cell models [31]. These observations underscore the
importance of aB-crystallin (sHsps in general) in diseases of aging
and protein aggregation, but their importance in mouse models has
not been examined. To this end, we examined behavioral deficits
when AD model mice were crossed mice lacking aB-crystallin/
HspB2.
Mice knocked-out for aB-crystallin and HspB2 (genes are
CRYAB and HSPB2, respectively) [32] are viable suggesting that it
is either non-essential or redundant during development. Due to
the close proximity (,1 kb) of the HSPB2 gene to CRYAB and the
sharing of promoter elements [33], the aB-crystallin knockout
mice are also deficient for a second sHsp, HspB2. The knockout
mice showed no significant difference in development and growth
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knockout mice consistently lost weight and body fat and
subsequently developed severe spine curvature (kyphosis) and
skeletal muscle degeneration [32].
The importance of sHsps in mice experiencing an increased
proteotoxic stress was previously not studied. In this report, we
inter-crossed between mice lacking aB-crystallin/HspB2 [32] and
Tg2576 transgenic mice [34], which over-produces the highly
aggregation-prone amyloid-beta. We observed that chaperone-
deficient transgenic mice developed severe locomotion defects
compared to mice with either chaperone deficiency alone or
transgene expression alone. Our results show that exacerbation of
protein aggregation and loss of chaperones produced a new
synthetic phenotype of motor defects in mice.
Materials and Methods
Mice and Animal Care
One male B6;SJL-Tg(APPSWE2576Kha) transgenic mouse
(Tg2576) [34] was purchased from Taconic Farms. The Tg2576
mice over-expresses the 695 amino acid isoform of amyloid
precursor protein (APP) harboring Swedish familial mutations
(K670N, M67IL) under the PrP promoter. These mice show
impairment in learning and behavior by 9 months and develop
extracellular amyloid plaques by 12 months. This mouse was out-
crossed to 129SvEv wild-type mice for 4 generations. The resulting
litters contained non-transgenic or transgenic mice. One breeding
pair of CRYAB
-/-/HSPB2
-/- mice in 129SvEv background [32]
were gifted kindly by Dr. Eric Wawrousek, National Eye Institute,
NIH, Bethesda, MD. Mice were maintained in a facility and
program accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International (AAA-
LAC) with the approval number A3307-01. The animal use
protocols were authorized by the Institutional Animal Care and
Use Committee (IACUC) of the Medical College of Georgia.
All behavioral experiments were carried out at the Small
Animal Behavior Core facility of the Medical College of Georgia
in rooms equipped with white noise generators (San Diego
Instruments, San Diego, CA) set to provide a constant background
level of 70 dB and ambient lighting of approximately 25–30 Lux
(lumen/m
2). Test subjects were handled daily for several minutes
(each) for at least one week prior to experimentation. Animals
were transferred (in their home cages) to the behavioral testing
rooms each morning approximately 30 min before the beginning
of experiments. Measures were taken to minimize pain or
discomfort in accordance with the National Institute of Health
Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23) revised 1996. Significant efforts were also
made to minimize the total number of animals used while
maintaining statistically valid group numbers. All procedures
employed during this study were reviewed and approved by the
Medical College of Georgia IACUC and are consistent with
AAALAC guidelines.
Generation of the required genotypes
To generate aB-crystallin/HspB2 deficient mice expressing the
transgene, transgenic mice in 129SvEv background were crossed
with the CRYAB
-/- mice. The resulting litters contained
CRYAB
+/-/HSPB2
+/-, mice with equal numbers of non-transgenics
and transgenics. The CRYAB
+/-/HSPB2
+/- transgenic mice were
crossed with CRYAB
+/-/HSPB2
+/- littermates to generate (i)
CRYAB
+/+/HSPB2
+/+,T g
0/0 (hereafter referred to as WT); (ii)
CRYAB
+/+/HSPB2
+/+,T g
+/0 (hereafter referred to as WTTg); (iii)
CRYAB
-/-/HSPB2
-/-,T g
0/0 (hereafter referred to as KO) and (iv)
CRYAB
-/-/HSPB2
-/-,T g
+/0 (hereafter referred to as KOTg) in
addition to parental genotypes CRYAB
+/-/HSPB2
+/-,T g
0/0 and
CRYAB
+/-/HSPB2
+/-,T g
+/0, which were not used further.
Genotypes of the mice were confirmed by PCR of tail genomic
DNA using appropriate primers as described in Brady et al [32] or
in Hsiao et al [34]. The use of littermates for all genotypes
minimizes the effect of out-crossing the mice. The genetic
variations between the two parental mouse strains are expected
to affect all four experimental genotypes identically.
Immunoblotting
To prepare brain lysates mice were euthanized using carbon
dioxide followed by perfusion with PBS. Brains were dissected out
from appropriate mice, frozen on liquid nitrogen and stored at -
80uC until use. Lysates were prepared by homogenization in lysis
buffer containing 50 mM Tris.HCl pH 7.5, 5 mM EDTA, 1%
Triton-X100 supplemented with HALT protease inhibitor cocktail
(Pierce). Lysate were cleared by centrifugation and the protein
concentration was estimated using the BCA kit (Pierce). Samples
were boiled in loading dye, separated by SDS-PAGE and
transferred to PVDF membrane. The membrane was blocked
using 10% milk in PBS with 0.1% tween-20. Primary antibodies
were anti-Hsp27 (Sigma), Anti-aBcrystallin (Stressgen), anti-Hsp70
(Stressgen) and anti-Ab (Sigma). Appropriate secondary antibodies
(rabbit anti-mouse or goat anti-rabbit) conjugated with horseradish
peroxidase were used followed by development of the immunoblot
by chemiluminescence (Danville).
Open Field Activity
Mouse open field activity monitors (27.9 cm 627.9 cm, Med
Associates St Albans, VT) were used for these experiments. The
following parameters were recorded for the 25 min test session:
horizontal activity (horizontal photobeam breaks or counts),
number of stereotypical movements, and vertical activity (vertical
photobeam breaks). Thus, spontaneous locomotor activity,
olfactory activity (rearing and sniffing movements) and stereotyp-
ical movements were assessed.
Hot Plate test (Supraspinal Nociception)
Individual mice were placed in the glass enclosed section of a
Hot-Plate Analgesia Meter, Accuscan Instruments, Inc., Colum-
bus OH. The temperature of the heating surface was elevated by
3uC per minute from a beginning temperature of 42uCt oa
maximum temperature of 49uC. The time elapsed (latency) before
the subject lifted and/or licked a hind paw or jumped was
recorded as a measure of nociception. Each mouse was given 3
trials separated by a 30-minute (minimum) inter-trial interval.
Fear Conditioning
Shock Threshold. A sequence of single foot shocks were
delivered to wild type mouse subjects placed on the same
electrified grid used for fear conditioning (see below) in order to
assess the shock (i.e., sensory perception) threshold. Initially, a 0.1-
mV shock was delivered for 1 sec, and the animals’ behavior was
evaluated for flinching, jumping, and vocalization. At 30-s
intervals the shock intensity was increased by 0.1 mA up to
0.7 mA and then returned to 0 mA in 0.1-mA increments at 30-
sec intervals. Threshold to vocalization, flinching, and then
jumping were quantified for each animal by averaging the shock
intensity at which each animal manifested a behavioral response to
the foot shock. This average was determined to be 0.5 mA and
used in subsequent experiments.
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subsequently evaluated for contextual and cued fear conditioning
using the mA shock levels determined in the experiments
described above. A two-pairing method of auditory cue and
mild foot shock were conducted during a 7 min test session.
Animals were initially allowed to freely explore the apparatus
(MED-VFC-NIR-M, Med Associates, St Albans, VT) for 3 min,
after which a 30-sec acoustic-conditioned stimulus (CS; white
noise, 80 dB) was delivered. At the end of the CS, a 2-sec shock
unconditioned stimulus (US) was applied to the grid floor. The
CS-US pairing was delivered again at the 5-min mark.
Context-dependent Freezing. To evaluate contextual fear
learning, test subjects were returned to the freeze monitor (i.e.,
same context) 24 hr after the training procedure described above,
and freezing behavior was scored for 5 min.
Cue-dependent Freezing. To evaluate cued fear learning,
the animals were placed in a different context (novel odor, lighting,
cage floor, and visual cues) 24 hours following contextual testing.
Baseline behavior was scored for 2 minutes, and then the CS was
presented for a period of 2 minutes, followed by another 2 minutes
period in which the auditory stimulus was absent.
Scoring Procedure. Subject movements in the freeze
monitor apparatus were determined via the Med Associates
Video-Tracking and scoring software. Data are expressed as
percent freezing in 60-s epochs, each epoch divided into 6 or 12 5-
s bins.
Statistical Analysis
All data were analyzed and graphed using SigmaSTAT and
SigmaPLOT software programs, respectively. Open field cumu-
lative counts were compared using 2-way repeated measure
ANOVA (genotype vs. time) with pair-wise multiple comparison
procedures using Holm-Sidak method. Open filed zone-time and
distance traveled data were analyzed by one way ANOVA. Data
from fear conditioning experiments were analyzed using two-way
repeated measure ANOVA with comparison between wild-type
versus knockout and non-transgenic versus transgenic genotypes.
Data from hot plate tests (temperature and time) were analyzed
using one-way ANOVA. Comparisons producing a p value ,0.05
were considered significant.
Results
Age-dependent decrease in the expression of aB-
crystallin in transgenic mice
As guardians against protein misfolding and aggregation,
chaperones protect the cells from the deleterious effects of
aggregation. Stressful conditions such as heat shock cause an
acute increase in misfolded proteins resulting in an increase in
demand for chaperones, which is normally met by the stress-
inducible expression of chaperones. On the other hand, a steady
increase in damaged proteins (oxidized and nitrosylated) takes
place due to aging, leading to a chronic demand for chaperones
and accumulation of damaged proteins. Such a reduction in
chaperone availability is thought to play a central role in triggering
the protein aggregation cascade of natively unstructured and
amyloidogenic polypeptides associated with several neurodegen-
erative diseases. Because misfolding and aggregation of the
amyloid-beta (Ab) peptide is a major hallmark of AD, we premised
that an age-dependent decrease in available chaperones might
exacerbate the increased demand for proteostasis mechanisms. We
investigated this possibility by examining the expression of Hsp70,
Hsp27 and aB-crystallin in the brains of non-transgenic and
transgenic mice at young (3 months) and older (7 months) ages by
immunoblotting (Figure 1A) and densitometric analysis of the
band intensities (Figure 1B). Due to the muscle-specific expression
of HspB2 and the unavailability of appropriate antibodies
recognizing mouse HspB2, we did not examine its expression in
the mouse brain. The expression of the human APP transgene was
examined using an antibody specific to human Ab. As expected,
only transgenic mice showed expression of APP and the band
intensities were significantly above the intensities in the same
molecular weight range in non-trangenic mice (p,0.05, two-
sample t-test). The expression of Hsp70 and Hsp27 were
unchanged at the ages tested irrespective of the transgene
expression or age of mice. A marginal elevation in the expression
of Hsp27 and Hsp70 observed in Figure 1B was not significantly
different between the two ages or between the two genotypes
(p.0.05, two-sample t-test). The equal expression levels of these
proteins also serve as control for equal protein loading.
Interestingly, the expression of aB-crystallin was significantly
decreased in older transgenic mice but not in non-transgenic mice.
Densitometric measurement of band intensities showed that aB-
crystallin levels of 3-month old transgenic mice were comparable
to that in non-transgenic mice. The levels of aB-crystallin in 7
month-old transgenic mice decreased significantly compared to 3-
month old transgenic mice (p,0.05, two-sample t-test). This
suggests that aB-crystallin may be an early indicator of protein
misfolding defects in the brains of transgenic mice.
Generation of transgenic AD mice lacking aB-crystallin/
HspB2
Based on our observations of reduced aB-crystallin in older
transgenic but not in non-transgenic mice, we hypothesized that if
this chaperone is protective, then its loss may show an exaggerated
phenotype. To examine if decreased aB-crystallin levels were
important for the manifestation of the behavioral phenotypes in
the AD model mice we crossed Tg2576 mice (B6/SJL back-
ground) with wild-type (CRYAB
+/+HSPB2
+/+)o raB-crystallin/
HspB2 knockout (CRYAB
-/-HSPB2
-/-) mice (129Sv background).
The breeding scheme is shown in Figure 2A. This intercross
resulted in litters with equal numbers of non-transgenic (Tg
0/0)o r
hemizygous transgenic (Tg
+/0) mice, which were heterozygous for
aB-crystallin/HspB2 (CRYAB
+/-HSPB2
+/-). The litters were inbred
to obtain mice of the following genotypes – (i) CRYAB
+/+HSPB2
+/+,
Tg
0/0;( i i )CRYAB
+/+HSPB2
+/+,T g
+/0; (iii) CRYAB
-/-HSPB2
-/-,T g
0/0
and (iv) CRYAB
-/-HSPB2
-/-,T g
+/0. From this point on, these mice
are denoted as WT, WTTg, KO and KOTg, respectively. (Mice
heterozygous for CRYAB (namely, CRYAB
+/-HSPB2
+/-,T g
0/0;
and CRYAB
+/- HSPB2
+/-,T g
+/0) that were also generated in this
cross were not used further.) By comparing only littermates for all
experimental genotypes, we minimized the influence of genetic
variation resulting from the parental strains. Further, any residual
effects of genetic variation are expected to be evenly distributed
between the four genotypes. The chaperone expression in each
genotype was confirmed by western-blotting two sets of brain
lysates from 7-month old mice for aB-crystallin, and Hsp27
(Figure 2B). The expression of Hsp27 was equal in all mice
suggesting that the expression of Hsp27 was not increased to
compensate for the loss of aB-crystallin/HspB2. The KO and
KOTg samples were devoid of aB-crystallin as expected. WT
samples showed higher amounts of aB-crystallin than WTTg
samples as observed in Figure 1. Expression of APP was observed
only in the transgenic samples (KOTg and WTTg) as expected
(not shown). Although the WTTg mice express low levels of aB-
crystallin, they are distinct from KOTg mice, which are devoid of
aB-crystallin since embryogenesis.
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The decrease in aB-crystallin expression in older transgenic
mice brains suggested that the over-produced APP may affect
proteostasis not only by increased demand for chaperone function
but also reduced expression. We premised that if aB-crystallin
protected the mice from Ab-mediated neuronal dysfunction, then
in its absence these deficits should manifest at an earlier age. It was
demonstrated that the Tg2576 mice showed behavioral changes as
early as 6–7 months of age [34]. Since the mice deficient for aB-
crystallin/HspB2 showed debilitating phenotypes about 9-10
months of age [32], we decided to investigate the behavioral
phenotypes of WT (n=9), WTTg (n=7), KO (n=15) and KOTg
(n=7) mice when they were 728 months (or 28–32 weeks). The
following tests were designed to examine both the effects of Ab on
locomotion defects in aB-crystallin/HspB2 deficient mice and the
effects of aB-crystallin/HspB2 loss on memory network defects in
Tg2576 mice.
Open field Test. Open field test is one of the most common
tests to monitor general motor activity, exploratory behavior and
measures of anxiety [35]. Normal behavior in mice is to seek the
protection of the periphery rather than the vulnerability of the
center. Mice that are less anxious are expected to spend more time
in the center. Mice that show signs of motor deficits are expected
to show lower horizontal distances and vertical movements. Mice
were individually placed in an open arena equipped with infrared
photobeams to monitor mice behavior for 30 minutes without the
experimenter being present in the room. The photobeams
recorded the following activities – (i) counts of ambulatory
(walking), stereotypic (repetitive activity, eg, grooming) and
vertical (rearing up) movements; (ii) distance travelled in the
center versus periphery and (iii) zone times in center versus
periphery were monitored.
First of all, WT and KO groups behaved similarly in terms of
vertical counts, stereotypic counts and ambulatory counts
indicating that loss of aB-crystallin/HspB2 alone had negligible
effect on locomotion at this age group (Figure 3A, B & C). Age
associated muscle degeneration reported with the knockout mice
was not manifested in terms of locomotion defects at this age group
as all 3 parameters counts of KO group of animals was
comparable to WT. Similarly, the WTTg group was comparable
to WT suggesting that the expression of mutant APP in mice did
not significantly affect locomotion by itself. Interestingly, when the
transgene expression was combined with aB-crystallin/HspB2
deficiency in the KOTg group, the effect was synergistically
enhanced compared to KO group (P,0.004, 2-way repeated
measure ANOVA) in ambulatory activity and vertical activity.
Differences were not statistically significant in stereotypic activity.
The total distance traveled by WT and KO mice were also very
similar underscoring the lack of locomotion deficits in aB-
crystallin/HspB2 knockout mice at this age. Distance traveled
(Figure 3D) and zone times in the center and peripheral regions
(Figure 3E) of the open field were also comparable (differences
Figure 1. Chaperone levels in AD model mice. (A) Immunoblots showing age-dependence of aB-crystallin expression in mice expressing
mutant human APP transgene. Brain lysates were prepared from two individual non-transgenic (NTg1 & NTg2) or transgenic (Tg1 & Tg2) mice each at
3 months or 7 months of age. Samples were immunoblotted for aB-crystallin, Hsp70, Hsp27, Ab and actin. 40 mg of total protein was analyzed. Similar
levels of Hsp70, Hsp27 and actin in all samples show equal protein loading. (B) Densitometric analysis of band intensities in A. Intensities were
compared by two-sample Student’s t-test for statistical signifcance. APP expression in Tg mice were significantly greater than NTg mice as expected
(p=0.006 at 3 months, p=0.017 at 7 months). aB-crystallin expression was significantly lower at 7-months compared to 3-months old transgenic
mice brain (p=0.044). aB-crystallin levels in 7-month old transgenic mice was also significantly lower than non-transgenic mice at similar age
(p=0.018). All other comparisons showed no significant differences.
doi:10.1371/journal.pone.0016550.g001
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traveled by WTTg mice was significantly lower than the WT
group, the zone times and distance traveled in the center and
periphery were statistically similar. Similarly, KOTg mice traveled
only about a third the distance traveled by KO mice but
differences between center and periphery were not significant.
Total distance traveled by KOTg mice was also significantly lower
than that of WTTg mice highlighting the synergistic effects
observed in ambulatory activity counts (Figure 3A). These results
suggest that the differences between transgenic (WTTg and
KOTg) and non-transgenic (WT and KO) mice were due to
locomotion defects rather than defects in anxiety or exploratory
behavior. The KOTg mice appeared to be unable to distinguish
between center and periphery compared the WT group (Figure 3E)
suggesting that they were significantly less anxious than WT mice.
Although, direct comparisons between KOTg and WT groups are
complicated, our data suggests synthetic effects of aB-crystallin/
HspB2 deficiency and APP transgene expression.
Hot plate test. To understand whether the observed
locomotion defects were coupled with sensory defects, we
examined the mice for pain sensitivity to thermal stimulus
(nociception). Each mouse was placed on a hot plate and the
temperature of the heating surface was raised by 3uC per minute.
The minimum time and temperature required to elicit response
(paw licking or jumping) was noted (Figure 4). Somatosensation
and its response as motor activity were scored to test for spinal
cord related reflexes. The KO, WTTg and WT mice showed
comparable responses and the differences were not significant.
Maximum latency and higher temperatures were required for the
KOTg group to elicit a response and were significantly greater
than all other groups of mice with respect to both time and
temperature. This result suggests that the combined effect of aB-
crystallin/HspB2 loss and transgene expression caused a decreased
sensory function not observed with each genotype individually,
thus underscoring the synergism.
Fear conditioning test. In order to examine whether
learning behavior was impaired in transgenic mice lacking aB-
crystallin/HspB2, we performed fear-conditioning test. In this test
paradigm the associative learning of a neutral cue (eg, sound tone)
or a neutral context (eg, environment) with a brief aversive
stimulus (eg, mild electric shock) is measured by monitoring the
freezing behavior in mice (Figure 5). Fear conditioning test was
performed by placing a mouse in a box equipped with a
mechanism for monitoring the freezing behavior of the animal
by recording photobeam breaks. The mice were first trained to
associate the surroundings or a sound pulse (cue) with the mild
aversive stimulus. Cue-dependent freezing was tested in a novel
environment (i.e., one with different lighting, and olfactory and
visual cues) and the freezing behavior associated with the tone was
measured. Context-dependent freezing was monitored to evaluate
the learned aversion of an animal for the environment associated
with the mild aversive stimulus.
No significant differences in freezing behavior were obvious
during the training period (Figure 5A) indicating that the
locomotion defects observed with WTTg and KOTg mice
(Figure 3) did not significantly affect the freezing response to the
mild aversive stimulus. During training, mice did not exhibit
freezing during the first cue-foot shock pair at 3 minutes, but
freezing increased in all mice during the second cue-foot shock
pair at 5 minutes. The subsequent increase in freezing at the end
of 6-minute period suggested an anticipatory behavior for a third
cue-foot shock pair or could also suggest decreased exploratory
behavior due to familiarity with the surrounding.
In response to a tone cue (Figure 5B), the mice behaved
similarly with no significant differences in the freezing behavior.
Mice did not exhibit freezing and explored their novel environ-
ment during the first 2 minutes. All mice responded readily to the
tone cue presented to them for 2 minutes by freezing. The mice
mostly stayed frozen beyond the 4-minute time point. These
results indicated good associative learning in all mice.
Interestingly, in response to contextual associative learning there
were notable differences (Figure 5C). First, WT and WTTg mice
froze similarly at the start of the experiment but differed
significantly at later time points (p=0.003). While the WT mice
rapidly froze subsequently and reached maximum freezing at the
2-minute time point, the WTTg mice only showed a gradual
increase in freezing till the 5-minute time point. This suggested
that context-dependent associative learning may be one of the first
manifestations of APP transgene expression. Second, KO and
Figure 2. Generation of the required genotypes of mice. (A)
Schematic diagram showing the mouse crosses that lead to the
required genotypes. (B) Immunoblots showing aB-crystallin and Hsp27
expressionintwosetsofmiceat7monthsofage.WTisCRYAB
+/+HspB2
+/+,
Tg
0/0;W T T gi sCRYAB
+/+HspB2
+/+,T g
+/0;K Oi sCRYAB
-/-HspB2
-/-,T g
0/0 and
KOTg is CRYAB
-/-HspB2
-/-,T g
+/0.
doi:10.1371/journal.pone.0016550.g002
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start of the experiment in comparison to their wild-type
counterparts. This is an intriguing result – mice lacking aB-
crystallin/HspB2 mice were seemingly better at contextual
learning than their wild-type counterparts. This result cannot be
satisfactorily explained by the locomotion defects in the knockout
mice because the same mice are normal in the cued experiment.
This leads us to suggest that the mice lacking aB-crystallin/HspB2
were perhaps hyper-sensitive to a particular contextual signal (such
as auditory, visual, olfactory or tactile), which may have allowed
them to associate this signal as a strong unitary cue with the
aversive stimulus. The nature of this cue is unclear.
Discussion
In this study, we aimed to investigate the effect of chaperone-
deficiency in a mouse model for AD. When expression of APP was
combined with loss of aB-crystallin/HspB2, we observed that new
phenotypes involving locomotion and sensory function deficits
were revealed. Neither loss of aB-crystallin/HspB2 nor transgenic
expression of APP by themselves produced these phenotypes. The
synthetic sick phenotypes underscore a negative synergy between
expression of APP, which is thought to increase the production of
the aggregation-prone Ab peptide and reduced chaperone (aB-
crystallin and HspB2) function.
When misfolding-prone proteins are overproduced, cellular
health may depend on its ability to also overproduce chaperones.
Figure 3. Open field test. Counts for Ambulatory (A), Vertical (B) and Stereotypic (C) activities of mice over a period of 25 minutes in the open field.
Symbol representations are - KOTg (open grey square; n=7), KO (closed grey square; n=15), WTTg (open black circle; n=7) and WT (closed black
circle; n=9). Mean values 6 SEM are plotted. Data were analyzed by two-way repeated measure ANOVA, which indicated that KOTg group showed
significantly less (p=0.004) than other groups. Differences were not statistically significant between other groups. (D) Total distance (in cm) traveled
by the mice over a period of 30 minutes. Mean values 6 SEM are plotted. Data were compared by t-tests. KOTg was significantly different from KO
(p=0.007) and WT (p=0.017). (E) Zone time in center (black bars) and periphery (grey bars) for the mice during the 30 minutes. Data were compared
by t-tests. Center zonetimes of both KO and KOTg were significantly different from WT (p=0.023 for KO and p=0.0006 for KOTg). Peripheral
zonetimes were similar for all groups. (n=7 for KOTg; n=15 for KO; n=7 for WTTg and n=9 for WT).
doi:10.1371/journal.pone.0016550.g003
Figure 4. Hot plate test. The duration of time to elicit a thermo-
sensitive reflex response in mice is shown on the left axis (black bars).
The temperature at which the response was recorded is shown on the
right axis (grey bars). Mean values 6 SEM are plotted. Data for different
groups were compared by t-tests. Both the time and temperature
required elicit a response in KOTg were significantly higher than those
for KO (p=0.022 and 0.031, respectively), WT (p=0.001 and 0.001,
respectively) and WTTg (p=0.05 and 0.05, respectively). All other
groups were statistically similar. WT is CRYAB
+/+,T g
0/0; WTTg is CRYAB
+/+,
Tg
+/0;K Oi sCRYAB
-/-,T g
0/0 and KOTg is CRYAB
-/-,T g
+/0. (n=7 for KOTg;
n=15 for KO; n=7 for WTTg and n=9 for WT).
doi:10.1371/journal.pone.0016550.g004
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have observed that aB-crystallin expression was high in glial cells
in areas surrounding plaques and tangles [20,36]. However, we
observed that aB-crystallin levels in brain lysates decreased in an
age-dependent manner in transgenic AD model mice compared to
non-transgenic littermates. The contrasting observations may be
attributed to the differences in methods - while others have
monitored relatively small regions by immunohistochemistry in
human AD brains [20,36], we monitored the expression levels by
immunoblotting lysates from the entire brains of a mouse model
for AD. In this regard, we would like to point out that other studies
have observed no significant differences in the expression of aB-
crystallin in various regions of AD brains by immunoblotting
methods [37], by mass spectrometry based protein identification
methods [38] and by immunohistochemical methods [39].
Further, we speculate that the difference between the human
and mouse results could be due to differential cellular responses
towards the entire gamut of pathologies in AD brains versus the
predominantly plaque pathology in the AD model mice used in
this study. However, the exact reasons for these observations are
presently unclear and require further experimentation.
We were unable to examine the effect of aB-crystallin/HspB2
loss on the deposition of Ab plaques in the mice because the
KOTg and the KO mice were considerably debilitated by the age
of 9–10 months as previously reported for aB-crystallin/HspB2-
deficient mice [32]. At this age, WTTg mice do not have
significant levels of plaque pathology and plaques develop only in
mice older than 10-12 months of age [34]. Immunohistochemical
examination of mice brains at 7 months revealed no plaques under
our experimental conditions (data not shown). However, it is
thought that plaques may not be causative and others have shown
that decreased dendritic spine density, impaired long-term
potentiation (LTP), and behavioral deficits occurred many months
before detectable plaques [40].
We observed a modest locomotor deficit in WTTg mice by
open field tests (Figure 4D) suggesting that the expression of hAPP
affected muscle function. In Tg2576 mice, expression of the APP
transgene has been observed in muscle tissue [41] where the
function of aB-crystallin and HspB2 is expected to be crucial [32].
The presence of amyloid oligomers in muscle cells has been shown
to have potent toxicity [42]. Thus, the high degree of synergistic
toxic effects of aB-crystallin/HspB2 loss and transgene expression
in the skeletal muscle precluded the examination of plaque
pathology at later ages. Because sHsps block the fibrillization and
toxicity of Ab [43,44] it is suggested that in the absence of aB-
crystallin/HspB2 enhanced Ab toxicity may contribute to the
manifestation of the synergistic phenotypes. An alternative
explanation for the locomotion defect is that since APP is
expressed throughout the brain in this mouse, it might contribute
to deficits in the brain motor centers. The locomotion defects
observed in the WTTg mice are important because these
transgenic mice are routinely used in learning and memory tests
that involve locomotion (eg, swimming in water maze). In
agreement with our observations, motor deficits in Tg2576 have
been observed at 6–7 months in a recent publication [45]. No
significant perturbation in the motor reflexes was observed in
WTTg mice as the mice could perceive and respond to thermal
stimulus in the supraspinal nociception (hot-plate) test. However,
reduced chaperone levels in the transgenic mice produced a
sensory defect suggesting that this synergism also affected
nociception.
In the WTTg mice, we also observed a significant limitation in
their ability to associate mild aversive stimulus with the
environmental context but not with an auditory cue. This
difference in associative learning can be interpreted as follows –
Contextual learning may be based on weak associations between
the footshock and diverse signals (including visual, olfactory,
auditory and sensory stimuli) and thereby differences between WT
and WTTg are manifested significantly [46]. It has been thought
that animals may associate only a subset of contextual elements,
which leads to weak associative learning. The inability of WTTg to
Figure 5. Fear conditioning test. Percent freezing of mice over time
during Training (Top), Cued test (middle) and Contextual test (bottom).
Mean values 6 SEM are plotted. Data were analyzed by two-way
repeated measure ANOVA. Differences between groups were not
significant for training and cued tests. In contextual tests, WT
performed significantly better than WTTg (p=0.003); difference
between WTTg and KOTg was significant (p=0.014); other groups
were not significantly different. Blue hatched boxes represent two
separate auditory signals (80dB) of 30 seconds each during training and
a single auditory signal for 2 minutes during cued test followed by 2 sec
foot shock. Symbol representations are - KOTg (red circle), KO (orange
circle), WTTg (yellow triangle) and WT (green triangle). (n=7 for KOTg;
n=15 for KO; n=7 for WTTg and n=9 for WT).
doi:10.1371/journal.pone.0016550.g005
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aversive stimulus indicates a reduced hippocampal function.
Contextual associative learning deficit in Tg2576 has been
previously observed [40,45]. On the other hand, associative
learning may be reliably paired with footshock when a strong
unitary cue (such as an auditory tone) is provided and a Pavlovian
response is established [47], which may overcome the minor
differences in learning between different genotypes. The ability of
WTTg mice to normally associate the fear of footshock with an
auditory cue indicates that there is no obvious impairment in
amygdala under these conditions. An alternative explanation for
the superior contextual learning in KO and KOTg mice is a
possibility that aB-crystallin and/or HspB2 may be involved in the
folding or degradation of proteins that modulate this learning.
Because molecular chaperones prevent excessive misfolding and
aggregation, cellular demand for chaperones are greater in aged
and stressed cells, which accumulate damaged proteins. Our
results demonstrating synergistic effects of reduced chaperones in
the context of a mouse model for AD highlights the in vivo
importance of sHsps in diseases characterized by protein
misfolding and aggregation.
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